期刊
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
卷 99, 期 4, 页码 -出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2020.115272
关键词
COVID-19; opportunistic Infections; fungal infections; aspergillosis; tocilizumab; pulmonary disease
This case highlights the importance of considering opportunistic infections when providing immune modulating therapy.
Tocilizumab, an interleukin-6 receptor antagonist, has been used to treat critically ill patients with coronavirus disease-2019. We present the case of a previously immunocompetent man with coronavirus disease 2019 who developed invasive pulmonary aspergillosis after treatment with tocilizumab, illustrating the importance of considering opportunistic infections when providing immune modulating therapy. (c) 2020 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据